{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:48:16Z","timestamp":1789048096953,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.urolonc.2025.12.017","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:42:45Z","timestamp":1769780565000},"page":"110981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The predictive value of lesion density in enhancing multiparametric MRI for detecting clinically significant prostate cancer"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-3293","authenticated-orcid":false,"given":"Ali","family":"Khatib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizo","family":"Al-Daqqaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E","family":"Gleave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles P.","family":"Mannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.12.017_bib0001","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0002","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eururo.2019.04.043","article-title":"Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis","volume":"76","author":"Kasivisvanathan","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0003","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0004","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa2406050","article-title":"Results after four years of screening for prostate cancer with PSA and MRI","volume":"391","author":"Hugosson","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0005","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3390\/diagnostics14171864","article-title":"Targeted prostate biopsy: how, when, and why? A systematic review","volume":"14","author":"Rebez","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76786-9","article-title":"The use of prostate specific antigen density to predict clinically significant prostate cancer","volume":"10","author":"Yusim","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0007","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/pros.24886","article-title":"Prostate specific antigen density and clinically-significant Prostate cancer: the influence of prostatic volume","volume":"85","author":"Robinson","year":"2025","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0008","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-410X.2011.10681.x","article-title":"The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume","volume":"110","author":"Corcoran","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0009","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0094-0143(05)70374-8","article-title":"The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration","volume":"24","author":"Tchetgen","year":"1997","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0010","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.juro.2017.10.042","article-title":"Pathological and 3 tesla volumetric magnetic resonance imaging predictors of biochemical recurrence after robotic assisted radical prostatectomy: correlation with whole mount histopathology","volume":"199","author":"Tan","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0011","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41391-023-00693-z","article-title":"MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients","volume":"27","author":"Baboudjian","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0012","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.juro.2018.06.041","article-title":"Multiparametric magnetic resonance imaging features identify aggressive prostate cancer at the phenotypic and transcriptomic level","volume":"200","author":"Beksac","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.prnil.2024.06.001","article-title":"A new parameter to increase the predictive value of multiparametric prostate magnetic resonance imaging for clinically significant prostate cancer in targeted biopsies: lesion density","volume":"12","author":"\u015eahin","year":"2024","journal-title":"Prostate Int"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0014","first-page":"323.e9","article-title":"The role of tumor density in predicting significant cancer on targeted biopsy of the prostate","volume":"41","author":"Erlich","year":"2023","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0015","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0016","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/pros.24368","article-title":"Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series","volume":"82","author":"Pellegrino","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0017","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/JU.0000000000003492","article-title":"Early detection of prostate cancer: AUA\/SUO Guideline part II: considerations for a prostate biopsy","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0018","first-page":"444.e11","article-title":"Utility of tumor diameter-to-prostate volume ratio for predicting the outcome of magnetic resonance imaging\/transrectal ultrasound fusion-targeted biopsy","volume":"43","author":"Kohada","year":"2025","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0019","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1089\/end.2024.0428.fts24","article-title":"The role of tumor volume ratio in predicting clinically significant prostate cancer on transperineal biopsy","volume":"39","author":"Avolio","year":"2025","journal-title":"J Endourol"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0020","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1002\/cncr.28216","article-title":"Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer","volume":"119","author":"Stamatakis","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0021","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1038\/s41598-024-57337-y","article-title":"PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4-10 ng\/ml","volume":"14","author":"Wen","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0022","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00345-024-04991-6","article-title":"Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center","volume":"42","author":"Jahnen","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.12.017_bib0023","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925005009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925005009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:51:00Z","timestamp":1784548260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925005009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1078143925005009"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.017","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The predictive value of lesion density in enhancing multiparametric MRI for detecting clinically significant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110981"}}